[144] YUM BRANDS INC SEC Filing

Rhea-AI Filing Summary

Form 144 filing for YUM Brands, Inc. discloses a proposed sale of 275 shares of the company's common stock through Merrill Lynch (Columbus, OH) with an aggregate market value of $41,962 and an approximate sale date of 10/01/2025 on the NYSE. The filer reports acquiring these shares on 02/05/2016 via an SAR exercise and sale from YUM Brands Inc., and indicates the securities were paid with stock. The notice also lists two recent sales by the same person: 263 shares on 08/06/2025 for $36,799 and 270 shares on 09/02/2025 for $39,222. The filing includes the required representation regarding material nonpublic information and signature attestation.

Positive

• Regulatory compliance: The filing provides required details (broker, acquisition method, dates, and signature attestation) consistent with Rule 144 disclosure.
• Transparency on recent activity: Prior sales on 08/06/2025 and 09/02/2025 are disclosed, giving investors a clear record of recent dispositions.

Negative

• Insider selling: The person for whose account the securities will be sold reported multiple sales (263, 270, and proposed 275 shares) within a short period, which may be viewed negatively by some investors despite small size.
• Limited context: The filing does not state whether sales are made under a Rule 10b5-1 plan or provide a plan adoption date, leaving the intent and timing framework unclear.

Insights

Securities Analyst

TL;DR: Insignificant insider disposition in absolute terms; disclosure provides required transparency but unlikely to move the market.

The filer proposes to sell 275 common shares valued at $41,962 against a reported outstanding share count of 277,535,696, indicating a de minimis percentage of the float. Two recent small dispositions (263 and 270 shares) in August and September 2025 are documented, showing a pattern of modest sales rather than a large, concentrated liquidation. From a market-impact perspective, these transactions are immaterial to YUM's capitalization. The filing satisfies routine regulatory disclosure requirements and includes the standard attestation regarding material nonpublic information.

Corporate Governance Expert

TL;DR: Routine insider notice; compliance is appropriate, but repeated sales warrant basic monitoring by governance observers.

The Form 144 identifies the nature of acquisition (SAR exercise) and lists broker details and sale dates, which aligns with governance expectations for transparency around officer/director/person disclosures. While the volumes disclosed are small relative to total outstanding shares, governance teams typically note recurring insider sales to ensure they are pursuant to pre-established plans or for personal liquidity. The form includes the required representation about lack of undisclosed material information, which is standard and necessary for Rule 144 notices.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 8890 Lyra Drive 5th Floor Columbus OH 43240	275	41962	277535696	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/05/2016	SAR Exercise and Sale	YUM Brands Inc			275	10/01/2025	Stock

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Scott Mezvinsky 1441 Gardiner LN Louisville KY 40213	Common	08/06/2025	263	36799
Scott Mezvinsky 1441 Gardiner LN Louisville KY 40213	Common	09/02/2025	270	39222

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the YUM (YUM) Form 144 disclose about the proposed sale?

The Form 144 discloses a proposed sale of 275 common shares via Merrill Lynch with an aggregate market value of $41,962 and an approximate sale date of 10/01/2025 on the NYSE.

Who acquired the shares and how were they acquired according to the filing?

The filing states the shares were acquired on 02/05/2016 through a SAR exercise and sale from YUM Brands Inc., and the amount to be sold is 275 shares.

Has the filer recently sold any YUM shares prior to this proposed sale?

Yes. The filer sold 263 shares on 08/06/2025 for $36,799 and 270 shares on 09/02/2025 for $39,222, as disclosed in the filing.

Does the filing state whether a 10b5-1 trading plan is in place?

The filing includes a field for plan adoption date but does not provide a specific 10b5-1 plan adoption date or indicate reliance on such a plan.

What representation does the filer make regarding material nonpublic information?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.